医疗资源稀缺与 COVID-19 死亡率的不平等:中国武汉住院病人的证据。

IF 2 3区 医学 Q2 ECONOMICS
Health economics Pub Date : 2024-11-11 DOI:10.1002/hec.4916
Dandan Zhang, Xiang-Ming Zhang, Xiao Liu
{"title":"医疗资源稀缺与 COVID-19 死亡率的不平等:中国武汉住院病人的证据。","authors":"Dandan Zhang, Xiang-Ming Zhang, Xiao Liu","doi":"10.1002/hec.4916","DOIUrl":null,"url":null,"abstract":"<p><p>Wuhan, China, where SARS-CoV-2 was detected first, has been recorded as one of the epicenters with the highest COVID-19 fatality rates worldwide. High COVID-19 fatality rates may stem from severe medical resource scarcity, especially in the early stage of the pandemic outbreak. In the first few weeks of the COVID-19 outbreak, Wuhan experienced the hardship of a severe \"hospital run\" period, when hospitals operated far beyond their maximum capacity and then soon transformed into \"inclusive healthcare,\" that is, every infectious person can access free medical treatment. Based on detailed administrative data of hospital admission and medical treatment for 1537 COVID-19 patients, we investigate how the COVID-19 fatality rates can be affected by the patient's socioeconomic status (SES) and differences in the effect between the two periods. Our estimation results show that low-SES patients had higher fatality rates during the \"hospital run\" period. Differential opportunities for hospitalization do not drive this inequality in fatality rates; rather, they are driven by the medical treatment after hospital admission, namely reduced treatment intensity and limited access to specific medical treatment and medications for COVID-19. When the government implemented the \"inclusive healthcare\" policy, severe medical resource scarcity was alleviated, and the inequality in fatality rates ceased to exist. These findings verify the existence of medical inequality among low-SES people amid severe medical resource shortages and also highlight the importance of rapidly increasing hospital capacity and medical supply in reducing possible unequal treatment and tackling inequalities in medical outcomes, especially during a public health crisis.</p>","PeriodicalId":12847,"journal":{"name":"Health economics","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Medical Resource Scarcity and Inequality in COVID-19 Fatality Rates: Evidence From Hospitalized Patients in Wuhan, China.\",\"authors\":\"Dandan Zhang, Xiang-Ming Zhang, Xiao Liu\",\"doi\":\"10.1002/hec.4916\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Wuhan, China, where SARS-CoV-2 was detected first, has been recorded as one of the epicenters with the highest COVID-19 fatality rates worldwide. High COVID-19 fatality rates may stem from severe medical resource scarcity, especially in the early stage of the pandemic outbreak. In the first few weeks of the COVID-19 outbreak, Wuhan experienced the hardship of a severe \\\"hospital run\\\" period, when hospitals operated far beyond their maximum capacity and then soon transformed into \\\"inclusive healthcare,\\\" that is, every infectious person can access free medical treatment. Based on detailed administrative data of hospital admission and medical treatment for 1537 COVID-19 patients, we investigate how the COVID-19 fatality rates can be affected by the patient's socioeconomic status (SES) and differences in the effect between the two periods. Our estimation results show that low-SES patients had higher fatality rates during the \\\"hospital run\\\" period. Differential opportunities for hospitalization do not drive this inequality in fatality rates; rather, they are driven by the medical treatment after hospital admission, namely reduced treatment intensity and limited access to specific medical treatment and medications for COVID-19. When the government implemented the \\\"inclusive healthcare\\\" policy, severe medical resource scarcity was alleviated, and the inequality in fatality rates ceased to exist. These findings verify the existence of medical inequality among low-SES people amid severe medical resource shortages and also highlight the importance of rapidly increasing hospital capacity and medical supply in reducing possible unequal treatment and tackling inequalities in medical outcomes, especially during a public health crisis.</p>\",\"PeriodicalId\":12847,\"journal\":{\"name\":\"Health economics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-11-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health economics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/hec.4916\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ECONOMICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health economics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/hec.4916","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

摘要

中国武汉是最早发现 SARS-CoV-2 的地方,也是全球 COVID-19 死亡率最高的震中之一。COVID-19 的高死亡率可能源于医疗资源的严重匮乏,尤其是在疫情爆发初期。在 COVID-19 爆发的最初几周,武汉经历了严重的 "跑医院 "时期,医院的运营远远超出了其最大能力,随后很快转变为 "包容性医疗",即每个感染者都能获得免费治疗。基于 1537 名 COVID-19 患者入院和治疗的详细行政数据,我们研究了患者的社会经济地位(SES)如何影响 COVID-19 死亡率,以及两个时期的影响差异。我们的估计结果表明,社会经济地位低的患者在 "住院期间 "的死亡率较高。住院机会的不同并没有导致死亡率的不平等,而是由入院后的医疗治疗导致的,即治疗强度降低,COVID-19 的特殊医疗和药物治疗受到限制。政府实施 "包容性医疗 "政策后,严重的医疗资源稀缺问题得到缓解,死亡率不平等现象也不复存在。这些研究结果验证了在医疗资源严重短缺的情况下,低社会经济地位人群中存在医疗不平等现象,同时也强调了迅速提高医院能力和医疗供应量对于减少可能出现的不平等待遇和解决医疗结果不平等问题的重要性,尤其是在公共卫生危机期间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Medical Resource Scarcity and Inequality in COVID-19 Fatality Rates: Evidence From Hospitalized Patients in Wuhan, China.

Wuhan, China, where SARS-CoV-2 was detected first, has been recorded as one of the epicenters with the highest COVID-19 fatality rates worldwide. High COVID-19 fatality rates may stem from severe medical resource scarcity, especially in the early stage of the pandemic outbreak. In the first few weeks of the COVID-19 outbreak, Wuhan experienced the hardship of a severe "hospital run" period, when hospitals operated far beyond their maximum capacity and then soon transformed into "inclusive healthcare," that is, every infectious person can access free medical treatment. Based on detailed administrative data of hospital admission and medical treatment for 1537 COVID-19 patients, we investigate how the COVID-19 fatality rates can be affected by the patient's socioeconomic status (SES) and differences in the effect between the two periods. Our estimation results show that low-SES patients had higher fatality rates during the "hospital run" period. Differential opportunities for hospitalization do not drive this inequality in fatality rates; rather, they are driven by the medical treatment after hospital admission, namely reduced treatment intensity and limited access to specific medical treatment and medications for COVID-19. When the government implemented the "inclusive healthcare" policy, severe medical resource scarcity was alleviated, and the inequality in fatality rates ceased to exist. These findings verify the existence of medical inequality among low-SES people amid severe medical resource shortages and also highlight the importance of rapidly increasing hospital capacity and medical supply in reducing possible unequal treatment and tackling inequalities in medical outcomes, especially during a public health crisis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health economics
Health economics 医学-卫生保健
CiteScore
3.60
自引率
4.80%
发文量
177
审稿时长
4-8 weeks
期刊介绍: This Journal publishes articles on all aspects of health economics: theoretical contributions, empirical studies and analyses of health policy from the economic perspective. Its scope includes the determinants of health and its definition and valuation, as well as the demand for and supply of health care; planning and market mechanisms; micro-economic evaluation of individual procedures and treatments; and evaluation of the performance of health care systems. Contributions should typically be original and innovative. As a rule, the Journal does not include routine applications of cost-effectiveness analysis, discrete choice experiments and costing analyses. Editorials are regular features, these should be concise and topical. Occasionally commissioned reviews are published and special issues bring together contributions on a single topic. Health Economics Letters facilitate rapid exchange of views on topical issues. Contributions related to problems in both developed and developing countries are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信